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INTRODUCTION 
The    stress  response  to  surgery  is  characterized  by 
increased  secretion  of  pituitary hormones   and  activation  of  the  
sympathetic  nervous system. These changes due to the stress response  
have   secondary  effects  on  hormone  secretion  from other  organs.   
For example,   release  of  corticotropin    from   the    pituitary   
stimulates  cortisol  secretion from the adrenal cortex. Arginine 
vasopressin which is secreted from the posterior pituitary  has effects 
on the kidney. In the pancreas, glucagon is released and insulin  
secretion may be diminished. The overall metabolic effect of the 
hormonal changes is increased catabolism which mobilizes substrates 
to provide energy .The hormonal changes also lead to  retention  of 
salt and water to maintain fluid volume and cardiovascular 
homeostasis.  
The changes  triggered by the stress response   are  short-lived   
and  well tolerated  by normal  healthy patients   belonging to class  1 
and 2  of American Society of  Anaesthesiologist  classification of 
Physical  Status. In patients with other co-morbidities   like 
myocardial ischemia, renal insufficiency, uncontrolled diabetes, liver 
disease and   cerebrovascular diseases  these changes can  be life 
threatening.     
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HISTORY OF STRESS FREE ANAESTHESIA 
 
  Before 1846, highly stressful procedures like intra abdominal 
surgeries were not attempted at all .  Rapper relates that surgical cases 
operated  for longer than twenty minutes will cause death of the 
patients. He felt  that intense pain  would exhaust the patient’s 
reserves. 
The concept of reduction of perioperative stress  to produce  a 
beneficial effect on recovery was conceived by George .W.Crile (1864 
- 1943). 
 Following that Harvey Cushing (1869 – 1939) combined 
regional blocks with ether anaesthesia to achieve smooth recovery . 
He used blood pressure measurement to mark the periods of stress 
during the surgery. Cushing confirmed that strict anaesthetic records 
maintained during surgery would prevent untoward events due to the 
stress response caused by surgery. 
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In 1957 P. Woodbridge  and M. Pinsker defined general 
anaesthesia as  
1) Paralysis 
2) Unconsciousness 
3) Attenuation of stress response  
In 1947, Michael Roizen found out that eventhough  general  
anaesthesia can prevent movement during surgery, it may not combat 
the sympathetic response to skin incision without the help of local 
anesthesia. 
Edward Lowenstein used large doses of morphine for 
hemodynamic stability during cardiac surgery .  
In 1967 short acting opioids,like fentanyl were used by Stanley 
instead of large doses of morphine to prevent the side effects of 
histamine release due to morphine . 
In 1959, neuroleptanaesthesia was introduced by De Castro 
using opioids  and  tranquilizer to achieve  stable hemodynamics 
during surgery. During the past  years a series of studies to identify 
markers of stress response have been conducted. Significant elevation 
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in catecholamines , adrenocorticotropic  hormone, cortisol, antidiuretic 
hormone and growth hormone were found to occur.  
In patients who were given anaesthesia with agents like ether, 
the  catabolic  state  produced by the stress hormones contributed  to 
delayed recovery  especially  after major surgeries .  
 Lundy’s balanced anesthesia combining several drugs was an 
important milestone in the development of strategies to attenuate the 
stress response . 
The pre - anaesthetic screening plays an important role in 
identifying and quantifying  the  co-existent diseases and makes way 
for  optimization of the  same . The recognition of the factors which  
initiate the stress response can be considered for modification in the 
pre-operative period itself.  Various anesthetic techniques and pain 
management strategies have been put into use to control the stress 
response.   Certain drugs like anxiolytic drugs, beta-blockers,  anti-
hypertensives and anti anginal drugs   are administered   
preoperatively  to combat the illeffects of the stress response .                       
Even from very early times anesthesiologists have relied on the 
hemodynamic variables such as heart rate and blood pressure to assess 
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the autonomic responses to surgery and stress.  Thereafter various 
tests to assess the neurohumoral outflow due to the stress response 
were deviced. 
The catecholamines  released due to stress cannot quantify for   
the level of stress response  because of the individual variation seen in 
the way each individual reacts to the circulating catecholamines.  
Thus the importance of attenuating the stress response  is well 
evident and our  study aims to compare the effects of oral Midazolam 
and oral  Pregabalin in attenuating the neurohumoral stress response 
by estimating the serum  cortisol levels. 
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AIM OF THE STUDY 
 
A Randomised Clinical Trial comparing Midazolam  
and Pregabalin as premedicants in attenuating neuroendocrine 
stress response during  General Anaesthesia  in Elective 
Surgeries. 
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OBJECTIVE OF THE STUDY 
Primary Objective: 
To study the pattern of  rise  in serum cortisol levels during 
surgery in two groups of patients  after premedicating one group with 
oral Midazolam  and another with  oral Pregabalin . 
Secondary Objective: 
To evaluate the changes in  
• serum prolactin  
• Plasma glucose  
• The hemodynamic  parameters like heart rate and blood  
pressure. 
Primary outcome measure : Serum cortisol  
Secondary outcome measure : Serum prolactin, plasma glucose, 
                                                        Heart  rate  and    blood pressure.  
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REVIEW OF LITERATURE 
Cuthbertson et al in 1932, described in detail the metabolic 
stress responses in four patients with lower limb injuries. Desborough 
et al1  says that stress responses refer to the humoral and metabolic 
changes following injury or trauma .The stress response to surgery is 
characterized by increased secretion of pituitary hormones and 
activation of the sympathetic system. 
  
In the review article ,Dr Manorama Singh2 quotes that  
hypotension, hypoxia, hypercarbia, acidosis, anxiety, emotion 
,temperature, anesthetic factors like drugs, laryngoscopy, pain,light 
plane of anaethesia  and surgical factors like duration of surgery, 
extent of tissue handling are  the  stimuli  triggering the neuro-
endocrine reflexes . 
The mediators of all these responses have been studied from 
time immemorial. Literature search takes us way back into the 1970s 
when various interventions were tried in attenuating the responses. For 
triggering such a response a complex interplay of substances between 
the hypothalamic pituitary axis ,the neuroendocrine system and the 
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autonomic nervous system occurs. It results in hypermetabolism and 
acceleration of most of the biochemical reactions so when the stress 
response is prolonged substrate mobilization and  immunosuppression 
occurs leading to increased morbidity and  mortality. 
In current anesthesia practice , no objective measurements for 
nociception or surgical stress exists. Inadequate analgesia during 
general anaesthesia may present as undesirable hemodynamic 
responses. 
For instance ,in 1990 Huiku et al3 reported that  the 
intraoperative changes in blood cortisol and prolactin during surface 
surgery using total intravenous anaesthesia in  forty ASA 1-2  patients  
Serum cortisol levels rose 30 minutes after extubation and serum 
prolactin increased in three situations after skin incision, extubation  
and  24 hours after surgery. 
Blood levels of cortisol and prolactin were studied by Riverso 
etal5 in twenty patients under going general anaesthesia under total 
intravenous and balanced anesthesia technique.  Both increased the 
serum cortisol levels but the increase in the total intravenous technique 
was more . 
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Deborah etal6 in their article have clearly outlined the 
mechanism of injury caused by the mediators like  cortisol and that it 
correlated  well with the severity of the insult and the response is not 
abolished by the administration of corticosteroids.  
Chana et al 7 reported that the rise in serum cortisol was 
independent of age, sex ,length of surgery and ana esthetic technique 
also they added that rise in serum prolactin was more in females and  
there was significant post induction surge. 
Barker et al 8 reported that since the cortisol increase is 
maximum during first four to six hours of the surgery,a series of 
samples are required to assess  the pattern of rise in serum cortisol  in 
a study comparing local and general anaesthesia  for cataract surgery 
in a group of diabetic patients. 
In another study by Zlata et al9, serum cortisol and prolactin 
were measured thirty minutes before and after induction,after 
extubation and 24 hours after sugery in a group of 50 patiens under 
going lower abdominal surgeries and they found cortisol was elevated 
after extubation. 
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Nicholson et al10  says that the amount of cortisol secreted 
following major surgery such as abdominal or thoracic surgery is 
between seventy five and hundred milligrams on the first day.  The 
endogenous cortisol production is between 25 and 30mg per 
day,circulating in a circadian pattern and the half life is between 60 
and 90 min. Plasma cortisol increase rapidly in response to surgery, 
peak values achieved within 4-6 hours,returing to normal after 24 
hours. 
Unase et al11 reported,they found low cortisol levels in patients 
undergoing anorectal surgeries under saddle block than in general 
anaesthesia.   
 
 So, general anaesthesia itself is a strong stimulus for increasing 
serum cortisol and methods for attenuating this response have been 
done for ages. So this study intended to study the humoral, metabolic 
and hemodynamic responses during general anaesthesia after 
administering tablet Pregabalin 150mg or tablet Midazolam 7.5mg 
orally one hour before surgery. 
Huncho etal12, In 1992 reported that in two groups of patients 
undergoing total abdominal hysterectomy and general anaesthesia 
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with or without epidural blockade , serum prolactin concentration 
were increased during and after the surgery in both groups. While 
cortisol levels were low in the second group. 
 George et al13 in their study mentioned that plasma 
catcholamines did not cause any significant change before, during or 
after the procedure.  Most of the studies reported assessed the 
hemodynamic parameters associated with stress response. 
 
Seyed etal14 in another study  found  clonidine and gabapentin 
to blunt hemodynamic responses during intubation. They compared 
clonidine 200mcg with 900mg oral gabapentin as premedication 120 
minutes before operation, with a placebo.  They concluded that both 
clonidine and gabapentin have effective role in blunting hyperdynamic  
responses after laryngoscopy, more so with gabapentin. 
So, many techniques were tried to attenuate the neuroendocme 
stren response as like in the above studies. All these literature searches 
led to further searches into finding a drug that could really be as  
effective as a premedicant in attenuating the neuroendocrine response. 
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Kain et al15 reported that, postoperative outcomes were good in 
patients given midozolam ,those treated with midazolam 
preoperatively self-report improved postoperative  recovery. 
 McEvoy etal16 reported that, T.Midazolam is reviewed in the 
Hazardous Substances Database of National Library of Medicine. It 
states that Midazolam Hydrochloride is absorbed rapidly from the GI 
tract, with maximum plasma concentrating usually occurring within 1 
hour. 
Bailey etal17 reported that respiratory depression may be caused 
by potentiation when administered along with opioids. 
Likman-Mui etal18 reported that many other studies  highlighted 
that the benefits of Midazolam where the anxiety score was less in 
patients undergoing upper Gastro Intestinal scopy when treated with 
7.5mg oral Midazolam. 
 Heine etal19 reported that, also in another study in patients 
undergoing intraocular surgery using retrobulbar anesthesia, even 
though Midazolam led to higher sedation scores than placebo only one  
was deeply sedated.  In patients who received low dose midozolam no 
increase in leucocyte number  occurred. It has been shown that 
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retrobulbar anesthesia doubles  plasma adrenaline levels which can be 
modified by oral low dose Midazolam. 
SG Danle et al20 in his article has concluded that oral 
Midazolam at 0.5mg/kg in children had better anxiolysis  and smooth 
recovery. 
Biro et al21 reported , that a dose of 7.5mg Midazolam showed 
the best relation between desirable and undesirable effects. 
 Ravitsky et al22 reported that Midazolam offers the benefits of  
balanced anesthesia, reduced alertness  ,and reduced blood pressure 
with no clinically significant adverse events.  
Lisa et al23 reported that, in a study comparing oral clonidine 
4mg/kg and oral Midazolam as preanaesthetic medications in the 
pediatric tonsillectomy patient,  recommended the preferential use of 
Midazolam as a preanaesthetic medication in children undergoing 
tonsillectomy because Clonidine did not offer a better recovery 
profile. 
Kumkum Gupta et al 24 reported that, the attenuation of 
hemodynamic responses to intubation using Pregabalin and Clonidine 
and they found both were effective premedicants.  They also stated 
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that since there was no respiratory depression it may be used in 
asthmatics  . 
Agarwal et al25 suggest that oral preoperative single dose of 
Pregabalin 150mg is an effective method for reducing postoperative 
pain and opioids consumption in patients undergoing laparoscopic 
cholecystectomy. 
Elinor Ben-Menachan26 has reported that Pregabalin does not 
bind to plasma proteins and not subject to hepatic metabolism,. 
Ashokkumar27 et al  reported that the  preoperative use of    Pregabalin 
shortens the time to achieve effective range of movements  in the knee 
joint . 
Rastogi28  et al reported that oral pregabalin premedication 
attenuated the pressor  response after  air way instrumentation in a 
dose-related fashion and 150mg per dose was found to be optimal. 
Baidya etal29 reported that  there is no clear evidence that the 
perioperative use of Pregabalin reduces postoperative pain intensity. It 
exihibits significant opioid sparing effects effects like vomiting. 
Schulmeyer et al 30   supported the same. 
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  Sundar et al31 studied the effects of premptive Pregabalin on 
attenuation of stress response to endotracheal intubation and opioid 
sparing effect in patients undergoing off pump coronary  artery bypass  
grafting. The catecholamine  secretion was not decreased.They 
concluded that it is not the plasma concentration of catecholamine that 
did matter but it was the reactivity to catecholamine that really counts. 
When this is the case,serum cortisol estimation seems to be a 
better indicator for postoperative outcomes after administration of 
general anaesthesia. 
The safety of both  Midazolam and Pregabalin have been 
validated in the literature search and they have worked well as far as 
the hemodynamic response is concerned and our study tried to find out 
the hormonal influences of the premedicants. 
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THE METABOLIC STRESS RESPONSE 
The metabolic stress response to surgical stress differs from that 
of starvation. Instead of preserving bodymass that occur during 
starvation,surgical stress causes “auto-cannibalism ”. This may  result 
in    loss of fat due to lipolysis   and  loss of lean body mass due to 
proteolysis. 
In patients under stress the glucose uptake into the cell is 
limited by insulin resistance. So despite normal glucose oxidation 
pathway, gluconeogenesis is activated leading to hyperglycemia. 
Stress causes immunodepression, recurrent infection and 
impaired wound healing.  
Granulocytosis and thrombocytosis occur in response to 
increase in interleukin-6 and acute phase reactants. Decreased 
fibrinolysis due to reduced tissue plasminogen activator and increased 
plasminogen activator inhibitor is also found. Both procoagulant state 
and decreased fibrinolysis   may predispose to deep vein thrombosis 
and pulmonary emboli in the postoperative period. 
The secretion of acute phase reactants is stimulated by increased 
endogenous corticosteroid.  
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ILLEFFECTS OF STRESS HORMONES: 
Increase in cardiac output occurs due to  vasoconstriction of the 
peripheral and splanchnic vessels   while vasodilatation occurs in  
coronary  and cerebral vessels.    
 Increase in heart rate,   blood pressure,  myocardial contractility 
increases oxygen demand.   
The respiratory rate also  increases.  
Sodium and water retention occurs resulting in decreased 
urinary output. 
 Immunosuppression predisposes to infection. 
 Substrate mobilization causes protein breakdown and 
hyperglycemia  leading to weight loss. 
 Coagulation problems may cause serious complications. 
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The       following  flow chart gives the metabolic   mileu during  
stress resulting in hyperglycemia , lipolysis and proteolysis. 
                   STRESS AND METBOLISM 
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Beta oxidation  of 
fatty acid 
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LOSS OF ENERGY RICH BONDS  
 
Glucose metabolism 
 Glycolysis                          Gluconeogenesis 
 
“wastes 4 – P  bonds / cycle” 
Fat metabolism 
     lipolysis                                  re-esterification 
 
“wastes 8mol ATP / cycle” 
      
         The alterations that occur in the metabolism of glucose , protein  
and fat cause wastage of the energy rich  phosphate bonds  which 
increases the metabolic requirements in the postoperative period.  A 
patient who is nil per oral and who is dependent  entirely on 
intravenous infusions may find it difficult to replenish the exhausted 
resources. 
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The intensity of the stress response depends on 
 Duration of operation, 
 Degree of injury , 
 Amount of blood lost during the procedure 
 Intensity of postoperative pain . 
                 Following the secretion of cortisol, an increase in 
levels of leptin and acute phase reactants occur especially in the 
levels of C- reactive protein. 
Recent evidence suggests that salivary cortisol estimation 
as a non ivasive and reliable method for assessing the stress 
response. The salivary cortisol seems to increase within few 
minutes   and shows good correlation with the serum levels. 
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THE TRIGGERS OF STRESS RESPONSE AND THE STRESS 
HORMONES 
THE STIMULUS FOR STRESS RESPONSE: 
Hypoxia ,  Hypotension ,  profound hypothermia,  induction,  
intubation,  extubation,light plane of anaesthesia, unneutralised pain,  
surgical manipulation,  intraoperative complications, wound healing 
and inflammation. 
THE PATHWAY: 
The stimuli travel to the limbic system and  from there   to the   
posterior hypothalamus. The   posterior hypothalamus  controls  the    
release of various hormones from pituitary like Arginine vasopressin, 
adrenocorticotropic hormone and aldosterone .They in turn release 
cortisol  and catecholamine  through the stimulation of the adrenals 
and the  autonomic  nervous system. This causes rise in heartrate, 
blood pressure and glucose levels.   
Corticotrophin (ACTH) is a 39 amino acid peptide, produced in 
the pituitary from its precursor, pro‐opiomelanocortin.. Surgery is 
one of the most potent activators of Corticotropin  which  stimulates 
the adrenal cortex to secrete cortisol and high  plasma concentrations 
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of both hormones can be found  immediately after the initiation of 
surgery .     
Decrease in growth hormone  also  occurs . The stress also 
interferes with the normal activity of thyroid hormones leading  to 
symptoms of hypothyroidism . 
 The stress response can be either acute or chronic.The acute 
stress response and chronic response to stress differs in the amount of 
growth hormone secreted. 
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MODULATION OF  THE STRESS RESPONSE 
Though the stress response can result in adverse metabolic 
events , they are useful during situation of hypovolemia and 
hypotension which may occur during the surgery.The catecholamines 
are needed for maintaining  blood pressure to ensure  end- organ 
perfusion. 
 THE PREOPERATIVE PERIOD  
The main goal of preoperative medication is to decrease the 
anxiety of surgery nonpharmacological methods like music , 
benzodiazepines like Midazolam, opioids like fentanyl have been 
known to modulate the preoperative stress response . 
INTRAOPERATIVE PERIOD 
The intraopertative stress response can be modulated by 
balanced anaesthesia  and refined surgical techniques like laproscopy . 
Volatile anaesthetics are ineffective in counteracting the 
metabolic response.The intravenous anaesthetics like propofol and 
etomidate have better control over the metabolic response than 
thiopentone sodium . Alpha 2 adrenergic agonist like clonidine and 
dexmedetomidine are more successful in attenuating the 
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hemodynamic and catecholamine response. Opioids are capable of 
decreasing hemodynamic  and cytokine response but failed to decrease 
the catecholamines during  cardiopulmonary bypass.  
Advantages of regional anaesthesia over general anaesthesia 
General anaesthesia makes the patient insensitive to pain and 
discomfort of surgery but it cannot abolish the afferent nervous input 
at the site of injury. Together it cannot antagonize the effects of 
interleukin-6 and tumour necrosis factor produced locally. 
Regional anaesthesia is reported to be superior to general 
anaesthesia in preventing the stress response .It  depends on the level 
of blockade, location of surgery and the drugs used. Lack of 
stimulation of hepatic glycogenolysis occurs due to reduced 
catecholamine response as seen in lumbar neuraxial anaesthesia.   
Continuous spinal techniques score better than thoracic epidural 
technique because vagal afferent nerves are not blocked in epidural 
anaesthesia .  
The drugs like chloroprocaine and bupivaccine are found to 
decrease catecholamine response than lignocaine . 
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ROLE OF THERMO REGULATION 
Maintaining perioperative normothermia  is another way of 
minimizing the stress response . Hypothermia elevates serum 
catecholamines due to shivering and vasodilatation which can even 
result in serious events like myocardial ischemia . 
POSTOPERATIVE PERIOD 
In this period extreme elevations of plasma ACTH  and cortisol 
are found suggesting that emergence from anaesthesia  is a potent 
trigger of stress response . Many agents failed to suppress this 
response. Literature search leads us to the conclusion that  very  few 
agents  can really blunt  the postoperative response . Continuous 
epidural analgesia ensuring a pain free emergence was found to be 
successful in preventing the catecholamine  surge but failed to 
decrease the metabolic response . Beta blockers cause end organ 
blockade and thereby reduce the metabolic response. Steroids  when 
given sixty to ninety  minutes before the onset of surgery was found to 
attenuate the cytokine secretion.  
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CONTROL OF GLUCOSE  
Acute hyperglycemia is to be prevented because it leads to 
increased  infection rates , reduced graft success  and osmotic dieresis 
leading to volume depletion. The beneficial effects of lowering this 
hyperglycemia with strategies like insulin therapy are attributed to the 
concomitant decrease in proinflamatory reactants. 
It is evident now that only a multimodal approach can be 
successful in attenuating catecholamine, neurohumoral and 
immunologic responses altogether . Miller ‘s textbook of anaesthesia  
highlights a schema for this multimodal intervention. 
 Premedication 
 Preoperative carbohydrate intake 
 Intraoperative glycemic control 
 Normothermia  
 Neuraxial techniques and non steroidal anti-inflammatory drugs 
instead of  opioids for pain relief 
 Avoiding early feeding and parenteral nutrition 
 early mobilization and non invasive surgery 
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With this in mind we were able to arrive at the hypothesis that 
any intervention in the preoperative period can be a good option to 
attenuate the stress response.The preoperative period is the one during 
which the patient can be counselled  easily.They are in the most 
optimal state of  the perioperative period  atleast in elective surgeries . 
We also thought of comparing two drugs one an analgesic and 
another a sedative so that we can findout whether  pain relief or 
sedation would be a better intervention in attenuating the stress 
response.  
MIDAZOLAM Is a short acting ,water soluble  benzodiazepine  
with good bioavailability when given orally and has been used  for 
producing anxiolytic effect and anterograde amnesia. Also it is found 
to have analgesic effect when given intrathecally or in caudal epidural.  
More recently antiepileptic drugs have been used for the 
treatment of acute postoperative pain and to reduce the postoperative 
analgesic requirements. PREGABALIN is   effective in preventing 
neuropathic  pain .It is well absorbed after oral administration and well 
tolerated with limited side effects  .  It does not have   any significant 
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drug interactions. Pregabalin undergoes  negligible hepatic 
metabolism and eliminated unchanged  by renal excretion. 
After getting convinced  with the   fact  that  Midazolam    and 
pregabalin were suitable agents for our study  a  protocol was drawn 
and sent for approval of ethical committee .    After the committee’s 
approval  our study was started.   
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PREGABALIN 
 
 
 
 
 
  
 
PHYSICAL AND CHEMICAL PROPERTIES 
S-(+)-3-isobutylgaba, analogue of GABA 
MECHANISM OF ACTION 
It binds to alpha2-beta subunit of presynaptic, voltage-
dependent calcium channels that are present in the central and 
peripheral nervous system. Reduces the release of several 
neurotransmitters like glutamate, norepinephrine, serotonin, 
dopamine, and substance P.  Pregabalin is inactive at GABAA and 
GABAB receptors.  
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PHARMACOKINETICS: 
ABSORPTION:  
It is  rapidly   absorbed after oral ingestion in empty stomach, 
maximum  plasma concentration occuring in one hour in the dose of 
150mg/day. 
ELIMINATION HALF LIFE:    6.3 hours 
METABOLISM AND EXCRETION: 
Pregabalin undergoes negligible metabolism in humans  and is 
excreted unchanged by the kidneys.  Pregabalin does not bind to 
plasma proteins. 
PHARMACODYNAMICS: 
Reduces the sensitization of dorsal horn neurons thereby 
reducing onset of chronic pain. Rapidly crosses the blood brain 
barrier.Reduces the communication between the nerves and this effect 
makes it a good antiepileptic. 
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ROUTES OF ADMINISTRATION: 
Oral tablets         :         dose:50-600 mg/day  
Adverse effects/Precautions: 
Dizziness, drymouth,edema, reduced blood platelet counts, 
increased blood creatinine kinase levels, rhabdomyolysis, muscle pain, 
weakness. 
Contraindication: Nil, except hypersensitivity to the drug. 
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MIDAZOLAM 
 
PHYSICAL AND CHEMICAL PROPERTIES :  
Available as Midazolam maleate in the strength of 7.5 mg . 
Chemically, midazolam maleate is is 8-chloro-6-(2-
fluorophenyl)-1-methyl-4H-imidazole[1,5-a][1,4] benzodiazepine 
maleate.   
In pH of 5 to 8   open-ring form becomes  physiologically 
active, lipophilic, closed-ring form .   
MECHANISM OF ACTION:. 
Like other benzodiazepines,  the effects of Midazolam are 
mainly mediated  via GABAA receptors at the limbic, thalamic, and 
hypothalamic levels. They produce  anxiolysis, sedation, hypnosis, 
skeletal muscle relaxation, and anticonvulsant  effects.   
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Benzodiazepines do not directly activate GABAA receptors, but 
require the endogenous ligand,  GABA to exert the effects. 
PHARMACOKINETICS  
ABSORPTION  
Midazolam is absorbed rapidly and completely after oral 
administration.  Due to the substantial firstpass effect,  bioavailability 
of oral Midazolam is between 30-70%.  It gets  rapidly redistributed in 
the tissues.    96-98% of Midazolam is bound to plasma proteins 
mainly to albumin. The relatively short duration of action of 
Midazolam is due in part to its very high metabolic clearance and 
rapid rate of elimination. 
METABOLISM  
Midazolam is almost entirely eliminated by biotransformation.  
Less than 1% of the dose is recovered in urine as the unchanged 
substance.  Midazolam is hydroxylated by cytochrome   isozymes in 
liver into  two main  metabolites: 1’-hydroxymidazolam  and 4-
hydroxymidazolam.    60-80% of the dose is glucuronidated and 
excreted in the urine in the form of the 1’-hydroxymidazolam 
conjugate.  Plasma concentrations of  1’-hydroxymidazolam may 
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reach 30-50% those of the parent compound.  1’-hydroxymidazolam is 
pharmacologically active and contributes significantly (about 34%) to 
the effects of oral midazolam.  Approximately 2-10% of an oral dose 
is excreted in feces. 
ELIMINATION: The  elimination half-life of  Midazolam ranges 
between 1.5 to 2.5 hours 
PHARMACODYNAMICS 
Midazolam slowly crosses into cerebrospinal fluid.  In humans, 
Midazolam has been shown to cross the placenta slowly and to enter 
fetal circulation,  small quantities of Midazolam are secreted  in 
human milk. It causes minimal haemodynamic changes. 
DOSE:  5mg to 15 mg tablets. 
CONTRAINDICATIONS 
Severe respiratory insufficiency, Severe hepatic insufficiency; 
Sleep apnea syndrome; Children;  Use in patients with known 
hypersensitivity to benzodiazepines  , Myasthenia  gravis. 
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 CORTISOL 
It is a steroid hormone    released from the adrenal gland in    
response to ACTH, which is secreted from the pituitary gland in the 
brain.  
It   is   a  glucocorticoid  and it is also known as hydrocortisone. 
Normal serum  values peak at 8.00 am around 6 to 23 mcg/dl   
Cortisol levels rise and fall during the day. The  highest levels are seen 
at 6.00 - 8.00 a.m and the lowest at  midnight. Daily around 20mg is 
produced but is capable of producing 150 to 300 mg per day.  
This circadian rhythm of rise and fall of cortisol is vital for 
normal cognitive function, metabolic activity and   
immunomodulation. It stimulates hematopoiesis, induces liver 
enzymes,  increases free water clearance.  
For cortisol to exert only beneficial effects, the relaxation 
response following cortisol surge is mandatory.  When there is a 
sustained increase it can cause impaired cognition , dyslipidemia , 
osteopenia , hyperglycemia and immunosuppression . Chronic 
increase impairs somatic growth by decreasing the growth hormone. 
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PROLACTIN   
It is a protein hormone which has aminoacids  similar to growth 
hormone. It is increased during stress response to surgery but it has 
only a  minimal effect on the body functions . Basically it increases 
during pregnancy  and controls lactation. It shows diurnal variation 
with the peak during  REM  sleep and seasonal changes . It is 
decreased during ovulation . 
BLOOD GLUCOSE: 
Usually there is an increase in blood glucose as soon as the 
surgical insult starts due to the effect of cortisol and catecholamines  
This  facilitates glucose production by increased hepatic 
glycogenolysis and gluconeogenesis. Also there is  increased 
peripheral resistance to insulin and to  glucose utilization. Prolonged 
hyperglycemia can cause impaired wound healing and predispose to 
infection in the perioperative period. 
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REFERENCE  VALUES: 
These are the reference values given in our laboratory 
Serum cortisol     :  -   6.7 to 22.6 mcg/dl (A.M) 
                                   2.9 – 17.3  mcg/dl(P.M) 
Serum  prolactin  :    - 3.34 -22.6 ng/ml. (males) 
          2 -29 ng/ml. (nonpregnant female) 
           20 -109 ng/ml. (pregnant female) 
        Random blood glucose :       70 to110  mg/dl 
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MATERIALS AND METHODS 
 
INCLUSION CRITERIA:  
 Patients who were willing to participate 
 Age: 18  to 55 years 
 American Society of Anaesthesiologist Class  1 and  II  
 Elective surgical procedures under general  anaethesia 
 Duration of surgery : 30 minutes and 180 minutes. 
 
EXCLUSION CRITERIA: 
         Preexisting co-morbidities [cardiac disease, diabetes, asthma, 
                                                   hepatic and renal dysfunction]  
anticipated difficult intubation,  
obesity,  
epileptics, 
pregnant patients, 
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patients on  antidepressants .  
After identifying  the eligible patient,  they were counselled on 
the day prior to sugery and separate consent got for the participation in 
the study . 
Those  patients in whom more than one  intubation attempt was 
required or laryngoscopy and intubation took more than 45 seconds 
were also considered as difficult airway.  
All menstruating women were  tested for pregnancy using card 
test.  Antidepressants can interfere with catecholamines ,so those 
patients on antidepressants  were also excluded. 
Those with baseline abnormalities in the lab values were also 
excluded.    
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PROCEDURE:  
All  consented patients , fulfilling the inclusion criteria were 
selected and divided into two groups .Group A received oral 
Midazolam 7.5 mg, Group B oral pregabalin 150 mg 60-90 minutes 
before  surgery with sips of water  (30-50 ml). They were randomly 
allocated to a particular group  using  computer generated  numbers . 
The ward staff nurse  administered  the drug kept in sealed envelopes.  
For uniformity all premedicated patients were assigned as  first case  
in the operative list . Both the patients and the person administering 
anaesthesia were unaware of the group. The details of the study  were  
explained to the participants in their own language and informed 
consent was obtained  on the day prior  to  surgery. 
In the preoperative ward selected patients’ first blood sample 
was collected around 8.00 am.since based on the circadian rhythm the 
cortisol levels  come to a peak level around 8’ o clock  in the morning.   
For all the cases posted for surgery  blood was drawn for grouping and 
crossmatch  on the morning of surgery , so along with that an extra 2 
ml [baseline sample] was drawn .    After administration  of the drug 
one hour before surgery  patients’ vitals were  monitored and given 
oxygen supplementation if SPO2 falls below  95%. They were  
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brought to the operation theatre in a stretcher accompanied by 
medical/paramedical personnel. Inside the theatre  the patients were 
connected to the monitors and an intravenous cannula was put  . 
Simultaneously  2 ml   blood [second sample] was  drawn and a 
crystalloid infusion of 6-8 ml/kg/hr was started. 
The anaesthetic technique was standardized in all patients.  
They were premedicated with Inj Glycopyrolate (10 mcg/kg),     Inj 
Pentazocine[0.5 mg/kg] intravenously  . After preoxygenation for five 
minutes they were  induced with  Inj Thiopentone[5mg/kg] , 
intubation   facilitated with Vecuronium(0.15mg/kg) and appropriate 
size endotracheal tube was put. Anaesthesia  was maintained by  
nitrous oxide:oxygen [4 :2]  and Sevoflurane. As a routine  in our 
setup patients will be premedicated with inj midazolam 1 mg for all 
those more than 50 kg  along with glycopyrrolate and opioid  . But in 
our study , IV midazolam was not given  so as to avoid overdosing of 
sedatives. 
Unanticipated difficult intubation cases (more than one attempt 
or  duration> 45 secs) were excluded .Within fifteen minutes after 
intubation third blood sample was  taken. At the end of surgery inj 
Glycopyrrolate 10 mcg/kg and inj Neostigmine 40-70 mcg/kg was 
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used to reverse residual  neuromuscular block and extubated.  
Immediately within fifteen minutes after extubation fourth blood 
sample  was taken after informing the patient. All patients were 
observed in the recovery room before shifting to the postoperative 
ward.  Along with serum cortisol , plasma glucose and serum prolactin  
were also  measured in the fourth sample.   
During the course of the surgery blood pressure  and pulse rate 
were noted down in the anaesthesia management chart maintained by 
the person  giving anaesthesia. On the  first postoperative   day   
around 8 .00 AM, when blood was collected for  routine 
investigations, additional 2 ml [fifth sample] was taken for the study .  
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SAMPLE ANALYSIS 
All the blood samples were centrifuged immediately and stored 
at  minus 200 C till the testing was done .Samples for blood glucose 
were collected in fluoride tubes and tested as early as possible. 
In  our biochemistry   laboratory  serum cortisol and serum 
prolactin were estimated using Beckman-coulter chemiluminescent 
hormone analyser. Blood glucose was estimated by Cobos C 3 11 
automated analyser . 
Blood samples taken for analysis 
1. Serum cortisol : Baseline,  After Premedication, Post 
intubation , Post extubation, Postoperative  sample after 
twenty four hours. 
2. Blood glucose Preoperative and Postoperative.               
Serum Prolactin after extubation 
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FLOW CHART OF EVENTS 
PREOP NIGHT:                          COUNSELLING AND CONSENT /  
T.RANITIDINE15OMG 
 
ON DAY OF SURGERY: 
1ST SAMPLE  8.00AM - FOR  SE CORTISOL 
 
 
1 HOUR BEFORE ORAL PREMEDICATION  UNDER SUPERVISION OF STAFF 
                 NURSE   
CONNECTED TO MONITOR 
             
 
SHIFTED    TO THEATRE IN STRETCHER ACCOMPANIED BY  TRAINED    
PERSONNEL 
                                                                         
2ND SAMPLE       AFTER SECURING    IV ACCESS     [PRE –INDUCTION] 
 
IV INJ.GLYCOPYRROLATE,PENTAZOCINE,THIOPENTONE,VECURONIUM 
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                                                                      INTUBATION 
 
3RD SAMPLE:               WITHIN  15 MINUTES AFTER    INTUBATION 
 
4TH SAMPLE:                WITHIN 15 MINUTES AFTER EXTUBATION                               
                                                                                         
5TH SAMPLE:                8.00 AM IN THE FIRST POSTOPERATIVE DAY   
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STATISTICAL ANALYSIS 
After consulting the statistician the sample size was set at 80 
patients. Intial pilot observation   showed a 10% difference between 
the control and the premedicated group.This study was designed to 
find out the difference between the two premedicants namely 
T.Midazolam7.5mg and  T.Pregabalin 150mg. After thorough review 
of previous studies approximately 40 patients including 5% for 
missing values were included in each group inorder to ensure a power 
of 80% which would permit a type 1 error of 0.05.The results were 
analysed  using SPSS Version 17 software with the help of the 
statistician. 
Normality was checked using  Kolmograv Smirnov test and it 
resulted in  a p> 0.005 for almost all the variables which implies that 
the data are normally distributed.  The students paired t-test  was used 
to compare the  mean change in the cortisol levels in the two groups. 
Categorical variables were analysed using  Chi Square test . Values 
that were not normally distributed or when the mean value was less 
than two times the standard deviation, were analysed with non-
parametric statistical methods. 
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All results were presented as means ± standard deviation. A 
  p  value < . 05 was considered as statistically significant. 
Eighty five patients belonging  to ASA physical status 1 and 2 
were enrolled  after getting  informed consent and  randomly allocated 
to the two groups. Both groups  were comparable in age,  gender 
variability, the type of surgery and the mean duration of surgery. 
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Table-1    :  POPULATION  CHARACTERISTICS 
GROUP 
 
MIDAZOLAM 
N=37 
 
PREGABALIN 
N= 48 
AGE (YEARS) 33.45 ± 11.92 31.27± 11.17 
SEX  (M:F) 16:21 24:24 
DURATION OF 
SURGERY  (HRS) 
2.17 ± 0.77 2.11± 0.62 
 
 
 
 
50 
 
Table 2 :  CORTISOL  LEVELS IN MIDAZOLAM  AND  
PREGABALIN  GROUP 
 MIDAZOLAM 
mean ±sd ( mcg/dl) p value 
PREGABALIN 
mean ±sd (mcg/dl) p value 
C1:C2 14.76±4.4 :  
11.56 ± 6.0 
p = .002 14.97±7.16  :  
11.59± 7.8 
p=.014 
C1:C3 14.76±4.4 :  
13.52 ± 6.7 
p = .019 14.97±7.16 :  
13.6 ± 6.88 
p=.021 
C1:C4 14.76±4.4 :  
23.26 ± 10.3 
p < .01 14.97±7.16 : 
25.71±18.3 
p<.01 
C1:C5 14.76±4.4 :  
12.42 ± 3.2 
p < .01 14.97±7.16 :  
11.63± 5.84 
p=.01 
C1: baseline cortisol  C2: cortisol after premedication,  
C3: cortisol after intubation     C4: cortisol after extubation,  
C5: cortisol after 24 hours 
Baseline cortisol value is the value that is measured in the 
sample taken  around 8.00 A.M. This is the time when the cortisol 
levels show a physiologic peak. This value is  comparable in both the 
groups. The rest of the values were   compared with the respective 
baseline value.    
  There was a significant reduction in the cortisol level after 
premedication when compared to the baseline value in both the groups 
(Midazolam-p=.002/ Pregabalin-p=.014) 
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. There was significant difference between the baseline cortisol 
level and the cortisol level after intubation( p < 0.01) in both groups. 
Both groups had almost constant levels of serum cortisol during the 
surgery with a  peak after extubation. 
There was a increase in serum cortisol levels after extubation in 
both the groups which was statistically significant (p < 0.01).The 
mean value after extubation was slightly greater in the Pregabalin 
group  than the Midazolam group.The  serum cortisol levels 
returntobaseline values within twenty four hours after surgery in both 
the groups. 
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Table 3:  SERUM PROLACTIN 
GROUP 
POSTOPERATIVE  
VALUE 
ng/ml 
 
NORMAL 
VALUE 
2.64 to 13.13    
ng/ml 
 
p=ns MIDAZOLAM 88.22±69 
PREGABALIN 65.18±41 
 
Both groups did not have significant reduction in serum prolactin. 
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Table 4 : BLOOD GLUCOSE 
GROUP 
PREOPERATIVE 
mg/dl 
POSTOPERATIVE 
mg/dl 
 
p = ns MIDAZOLAM 87±  12.38 124.6±37 
PREGABALIN 88.64 ±  13.62 126.08±33 
  
Both the groups did not have significant reduction in the blood 
glucose levels. 
 
 
 
 
54 
 
HEMODYNAMIC VARIABLES: 
Table 5 : HEART RATE 
GROUP Baseline 
rate/minute 
after 
premedication 
rate/minute 
after 
intubation 
rate/minute 
after 
extubation 
rate/minute 
after 24 
hours 
rate/minute 
Midazolam 
74.59±8.421 
73.59±7.11 
(ns) 
87.65±128 
(p<.01) 
83.19±10.3 
(p<.01) 
91.29±14.6 
(ns) 
Pregabalin 
78.17±10.82 
75.21±8.27 
(p=.002) 
85±12.41 
(p=.002) 
84.42±11.29 
(p=.002) 
90.21±12.4 
(ns) 
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In the Pregabalin group, after premedication, there was a 
significant decrease in heart rate(p=.oo2). 
 There was significant increase in the heart rate(p=.002) , 
systolic bloodpressure (p=.001) and diastolic blood pressure (p<.01)  
after  intubation. 
  There was a significant increase in  both the groups in the 
heart rate(p=.002) , systolic bloodpressure (p=.007) and diastolic 
blood pressure (p=.002)  after extubation. 
 There was no significant change in the hemodynamic variables  
after twenty four hours. 
       In the Midazolam group, there was no  significant decrease in the 
heartrate and diastolic blood pressure one hour after premedication 
though there was a slight decrease in systolic blood pressure. But there 
was significant increase in the intraoperative heart rate , systolic and 
diastolic blood pressure. There was no significant reduction in the 
hemodynamic variables  after twenty four  hours
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Table 6 : SYSTOLIC BLOOD PRESSURE 
 
Group 
 
baseline 
mm of hg 
After  
premedication 
mm of hg 
After intubation 
mm of hg 
After 
extubation 
mm of hg 
After 24 
hours 
mm of hg 
Midazolam 114.22 ±11.74 
 
118.27±12.47 
(p=.025) 
131.35 ± 12.06 
(p<.01) 
132.62 ± 10.7 
(p<.01) 
135.35 ± 24.9 
(ns) 
Pregabalin 118.56± 12.55 114.77 ± 15.01 
(ns) 
127.48 ± 13.42 
(p=.01) 
125.56±12.83 
(p=.007) 
131.30 ± 22.1 
(ns) 
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Table 7 : DIASTOLIC BLOOD PRESSURE 
 
 
Group 
Baseline  
mm of hg 
After 
premedication 
mm of hg 
After 
intubation 
mm of hg 
After 
extubation 
mm of hg 
After 24 
hours 
mm of hg 
Midazolam 75 ± 9.79 
 
73.03±9.84 
   ( ns)  
81.96±10.36 
(p=.001 ) 
80.84±12.29 
(p=.014) 
83.18±11.7 
(ns) 
Pregabalin 74.31±8.60 71.48 ±9.75 
(ns) 
83.56±11.34 
(p<.01) 
80.85±9.20 
(p=.002) 
86.75±13.08 
(ns) 
. 
 
 
 
 
 
 
58 
 
Table -8  PREOPERATIVE COMPLICATION 
GROUP NUMBER NONE DESATURATION DROWSINESS 
MIDAZOLAM 37 8 2 27 
PREGABALIN 48 43 0 5 
 
 
In the preoperative period  most of the patients in the 
Midazolam group were sleeping before induction     (p <0.01)  while 
only five patients in Pregabalin group were feeling sleepy. 
None of them desaturated ( i.e.SpO2 < 95%)  in Pregabalin 
while in the Midazolam group two patients desaturated(p < 0.01). and 
O2 supplementation was  done with Hudson mask in the preoperative 
room  
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Table -9  PREOPERATIVE SEDATION 
GROUP 1 2 3 4 5 6 
p=0.001 MIDAZOLAM 2 0 0 24 11 0 
PREGABALIN 0 29 19 0 0 0 
 
RAMSAY SEDATION  SCORE   
1-anxious,restless 
2- Cooperative,tranquil  
3- Responds  to commands only 
4- Brisk response to tap / loud noise 
5- Sluggish response to tap / loud noise 
6- No response. 
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Preoperative sedation was assessed using Ramsay  sedation 
scoring system. Sedation scores were high in Midazolam group than 
the Pregabalin group (p < 0.01). Most of the patients were sedated and 
were feeling sleepy while they were put on the operating table. 
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Table-10   INTRAOPERATIVE COMPLICATIONS 
 NO NONE HYPERTENSION TACHYCARDIA BOTH  
p=ns MALE 37 24 7 3 3 
Female 48 37 3 7 1 
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There was no significant difference in both groups as far as the 
intraoperative  complications were concerned. In both the groups some 
of the patients had high blood pressure (more than 20% increase from 
baseline level) necessitating treatment with nitroglycerine in a dose of 
0.5 mcg/kg/min. Some of them were treated with extra doses of 
inj.Fentanyl 0.5 mcg/kg for tachycardia.  
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Table-11 POSTOPERATIVE COMPLICATIONS 
Group 
None 
Bucking 
During 
Extubation 
Postoperative 
nausea and 
vomiting 
Shivering 
Midazolam 25 3 4 4 
Pregabalin 40 5 1 2 
 
 In the postoperative period the patients belonging to Midazolam 
group had more nausea vomiting and shivering but our study failed to 
demonstrate significant difference in both the groups. 
 In the Pregabalin group patients five patients coughed on the 
tube. But, this was not statistically significant. 
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TABLE-   12     POSTOPERATIVE PAIN SCORE 
(Numerical rating scale) 
group 1 2 3 4 5 6 
Midazolam 4 2 1 17 7 5 
pregabalin 4 21 12 7 3 1 
 
Numerical rating scale:  
 
 
 
         After extubation all patients were asked to rate their pain by 
looking at the numerical rating scale. All of them were able to 
understand and  give a value to the intensity of the pain.  
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There was significant reduction in Pregabalin group (p < 0.01) 
than the Midazolam group.The patients belonging to the pregabalin 
group had a sense of wellbeing  and calmness. 
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Table-13  POSTOPERATIVE ANALGESIC REQUIREMENT 
Time after 
extubation 0-2 hrs 2-4 hrs 4-6 hrs 
M 30 7 0 
P 5 24 19 
 
Postoperative analgesic requirement was significantly low in the 
Pregabalin group . (p<..01) but in the Midazolam group most of them 
needed analgesics within two hours of  extubation in the postoperative 
ward. 
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DISCUSSION 
Our study intended to study the pattern of  rise of  serum 
cortisol in response to anesthesia and surgery after premedicating two 
groups of patients one  with Midazolam and another with Pregabalin.  
            Our results showed that the  increase in serum cortisol  was 
blunted by the administration of Midazolam and Pregabalin.This 
reduction was significant just before and after intubation and was not 
significant at the end of the surgery and extubation. 
                    The serum cortisol levels were around the baseline after 
twenty four hours  after surgery.This finding is consistent with the 
study conducted by Barker etal8. 
 The degree of  surgical manipulation  seems to  be play a major 
role in  triggering   the neuroendocrine stress reponse  as Unase et al 11  
in their study rightly said that ‘the  immunoendocrine response to 
surgical trauma is dependent on the surgical technique’. The finding in 
our study was consistent with this observation  and the post extubation 
cortisol values were very high. 
In our study we found that  serum  prolactin  levels were very 
high in both the groups after extubation and both the drugs did not 
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produce a favourable effect on the neuroendocrine stress response at 
that point of time.Though serum prolactin levels do not cause major  
metabolic derangements, it is regarded as a more reliable indicator of 
the stress response.This is quoted in a study by Riverso et al5.  
Induction of anaesthesia is a critical phase in the surgical 
management of patients. The neuroendocrine stress response resulting 
in increase in the cortisol levels can trigger an array of events which 
results in undesirable elevations in hemodynamic parameters, altered 
metabolic derangements leading to protein breakdown,  
immunomodulation  interfering with wound healing. In our study we 
were able to demonstrate significant reduction in the post intubation 
serum cortisol values thus proving that both Midazolam and 
Pregabalin are good adjuvants for smooth induction of anaesthesia . 
Most of the studies done with Pregabalin in attenuating stress 
response compared hemodynamic parameters rather than the  
hormones.  The serum cortisol  levels  in  post extubation phase were 
high in Pregabalin group than the Midazolam group  which needs to 
be  further validated by more studies in future. The heart rate was 
controlled before induction by Pregabalin efficiently than Midazolam. 
This makes Pregabalin a good anxiolytic agent. The role of Pregabalin  
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as an anxiolytic is well showed by Baidiya et al 29  where they say  that 
Pregabalin is effective in the treatment of generalized anxiety disorder. 
Pregabalin  has less effect on the hemodynamic parameters so there 
was no statistically significant decrease in the systolic and diastolic 
blood pressure after  premedication. 
In our study, a decrease in systolic blood pressure before  
induction  was observed  in  the oral Midazolam group which may be 
due to mild cardiac depression  caused by Midazolam in therapeutic 
doses.This is consistent with the study done by Heine etal19 in which 
they quote that both systolic and diastolic blood pressure decreased 
significantly in  patients treated with Midazolam .   .      
The increase in hemodynamic variables observed in the 
intraoperative period need not be directly attributed to the 
neuroendocrine stress response because George et al have concluded 
in their study that  the  way in which the body responds to the increase 
in catecholamines  is always not proportional to the catecholamine 
levels. They also added that cortisol and prolactin estimation are more 
reliable than the hemodynamic responses in quantifying the stress 
response. 
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         In our study we found that both Midazolam and Pregabalin 
failed to suppress serum prolactin levels and  prevent hyperglycemia  
after extubation. The stress hormones are released more in response to 
surgical manipulation and emergence from anaesthesia and  
preoperative drugs have got little control over the stress hormones at 
the end of surgery. Modifying the surgical technique, minimal tissue 
handling,  reducing the duration of surgery may be successful in 
allieviating the neurohumoral stress response. 
Pregabalin seems to be superior in maintaining stable 
hemodynamics and so it scores well over Midazolam as a 
premedicant. Our study demonstrated that in the group premedicated 
with Midazolam there was statistically significant drowsiness            
(p <0.01) before induction . Ravitsky etal22 also found that after one 
hour of oral Midazolam ingestion there was significant reduction in 
alertness  but no adverse events occurred.None of the patients in the 
Pregabalin group desaturated while two of them did in Midazolam 
group requiring oxygen supplementation preoperatively.. 
The patients belonging to Pregabalin group were cooperative, 
alert, calm, in the preoperative period and a sense of well being  
prevailed  in the postoperative period  .The requirement of analgesia 
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was significantly delayed ( p< 0.01)  in this group in the   immediate 
postoperative period. 
But in the intraopertaive period there were complications like 
tachycardia, hypertension in the both the groups   necessitating 
intravenous infusion of nitroglycerine in the dose of 0.5 mcg/kg/min 
and additional doses of inj. Fentanyl 0.5 mcg /kg  in the postoperative 
period. 
 The  patients belonging to Midazolam group had more nausea, 
vomiting and shivering but our study failed to demonstrate statistically 
significant difference in  the incidence of postoperative complications 
in the two groups. 
In our study awakening was prompt in the Pregabalin group 
though  a few of them coughed on the tube. But  most of the patients 
were sleepy during  reversal and extubation in the Midazolam group. 
Kumkum gupta et al24 in their study have found out that Pregabalin 
maintained hemodynamic stability  and  did not cause any respiratory 
depression, proving to be safe in obese and airway compromised 
patients.   
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In our study it was found that almost all the patients had 
elevated blood glucose level and prolactin levels at the end of surgery. 
Miller’s textbook of anaesthesia says that the postoperative period is 
the most significant period in causing the stress response. Emergence 
from anaesthesia  and surgical manipulation cumulate to cause  a 
cascade of triggering factors  that bring about magnificient changes in 
the patient under anaesthesia. Our study was consistent with this 
reference . Both Midazolam and Pregabalin were able to decrease the 
cortisol level except during the postextubation phase . 
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SUMMARY 
This study was done to assess the pattern of rise of serum 
cortisol in patients premedicated with Midazolam and Pregabalin. A 
randomized prospective  study was carried out in 85 patients aged 
between 18 and 55 undergoing general anaesthesia for elective 
surgeries .Serum cortisol, serum prolactin , blood glucose, heart rate 
and blood pressure were measured at five times namely baseline, after 
premedication , after intubation, after extubation, and twenty four 
hours after surgery.  
Our study demonstrated that both Midazolam and Pregabalin 
were able to reduce the serum cortisol levels before and after  
intubation ( p < .01) thus proving to be good premedicants. We also 
found that both the drugs failed to decrease the neuroendocrine stress 
response following extubation at the end of the surgery. We found that 
with its advantageous therapeutic profile Pregabalin  proves to be 
superior to Midazolam in maintaining  stable hemodynamic 
parameters, anxiolysis with out undue sedation and efficient analgesia 
in the immediate postoperative period. 
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   Oral premedication given one hour before surgery  is feasible 
only in preoperative wards which are far away from the well –
equipped  theatre suite and trained airway personnel. 
   Also Pregabalin is found to be safe in hyperreactive airway 
disease. Pregabalin in the dose of 150 mg is safer than Midazolam in 
most of the populations and in places with little access to monitors. 
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CONCLUSION 
From this study it is concluded that 
Pregabalin  in the dose of 150 mg given per orally one hour 
before elective surgeries can attenuate the neuroendocrine stress 
response due to induction and intubation . 
This dose (150mg) is optimal in that it doesn’t cause undue 
preoperative sedation at the same time provides efficient analgesia in 
the early postoperative period . 
Midazolam is also effective in attenuating the humoral stress 
response but stringent monitoring is warranted to avoid  hypoxemia 
before induction  more so in obese and   in patients  with respiratory 
diseases. 
Better surgical skills and techniques have got a major role in 
attenuating neuroendocrine stress response in addition to the 
conventional anesthetic interventions.  
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s.no NAME age sex type of surgery group C1 C2 C3 C4 C5 pro G1 G2 
1 SUMITHRA 27 f tonsillectomy P 7.6 5.8 6.4 8.4 6.02 112 106 143 
2 PARANTHAMAN 36 m laminectomy P 8 8.01 12.6 15 7.56 130 92 129 
3 CHINNADURAI 19   lap cholecystectomy P 23 2.42 6.17 24 6.4 53.2 88 160 
4 SIVAKUMAR 38 m r gynaecomastectomy P 20 11.9 17.3 15 8.21 26.8 90 94.4 
5 ANANADAN 25 m lap appendicectomy P 9.8 10.8 11.2 9.8 11.3 32.6 77 126 
6 KANNAN 35 m r monteggia # orif P 12 15.3 24.6 37 8.4 68.7 90 95 
7 BHAVANI 20 f torticollis release P 8.3 11.8 10.7 23 6.6 102 100 235 
8 LATHA 21 f lap cholecystectomy P 33 34.5 31.8 24 5.4 35.3 90 133 
9 CHELLAPANDI 48 m laminectomy P 3.2 8.2 11.1 96 5.6 96.8 84 116 
10 JEYARANI 42 f chronic abscess neck excision P 14 5.7 6 21 10.6 81.6 93 138 
11 SURESH 35 m larynx growth excision P 7.5 6.3 6.2 22 10.1 117 90 108 
12 MAHALAKSHMI 23 f l fibroadenoma excision P 17 19 15 26 15.2 97.7 78 133 
13 GRACE 40 f lap cholecystectomy P 9.7 10 8.9 18 8 86.6 90 251 
14 BAOERAJ 50 m l  mastoidectomy P 3.7 3.4 2.8 22 5.6 49.9 78 94 
15 MAHALAKSHMI 21 f cervical node excision P 15 5.3 8.8 22 26 73.3 92 102 
16 GUNAVALLI 27 f tubal recanalisation P 17 14 11.5 7.4 15 98.2 88 120 
17 RAJESWARI 23 f l fibroadenoma excision P 16 3.1 2.4 25 11.5 41.8 84 130 
18 RAMESH 32 m r mastoidectomy P 20 20.2 12.9 4.1 13 28.5 80 111 
19 SENTHIL 22 m lap appendicectomy P 20 17.4 17.9 18 15.6 31.2 74 127 
20 FATHIMA 32 f lipoma shoulder excision P 15 4.04 4.32 4.3 16.1 82.8 90 113 
21 PRAMILA 37 f hemithyroidectomy P 6.3 6.3 5 5 12.6 171 83 96.8 
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6 68 62 93 85 
10
1 101 80 101 63 120 70 118 68 120 90 1.2 2 3 0 0 0 2 
7 90 82 88 71 93 106 60 106 53 137 50 113 73 130 72 2 2 1 0 0 0 3 
8 58 68 74 65 83 128 70 128 70 136 82 120 68 140 86 3.1 2 1 0 0 0 3 
9 62 66 90 83 81 128 71 128 80 130 100 128 94 136 75 2.3 2 2 0 2 0 3 
10 53 58 90 70 81 106 70 106 68 150 100 128 84 130 79 2.4 3 4 0 0 0 1 
11 82 80 68 88 72 126 70 126 82 140 86 126 69 136 59 1.4 3 2 0 0 0 3 
12 71 81 81 66 85 130 72 130 80 106 76 107 84 130 70 1.5 3 3 0 0 0 2 
13 90 82 92 
10
6 65 110 80 110 80 130 86 140 90 120 70 1.5 3 5 0 0 3 1 
14 73 66 93 95 68 106 70 130 68 112 72 106 68 140 76 1.2 3 2 0 0 0 3 
15 74 78 78 71 80 110 70 96 72 113 70 120 80 104 70 2.3 2 3 0 0 2 2 
16 80 81 66 90 81 130 80 108 62 120 80 136 92 130 88 2.2 3 2 0 1 0 3 
17 66 65 85 75 74 96 80 100 65 117 78 128 86 130 92 1 2 3 0 0 0 3 
18 67 70 71 72 91 108 70 110 70 120 84 126 92 140 100 1.3 3 4 0 0 0 2 
19 83 76 75 86 78 100 70 130 72 130 90 134 94 130 80 2.3 2 5 2 1 1 1 
20 78 71 78 95 97 110 68 136 70 136 86 156 90 130 76 2 3 2 0 0 0 3 
21 72 68 88 98 92 130 80 117 72 117 73 150 98 136 84 1.3 2 2 0 0 0 3 
 
  
s.no NAME age sex type of surgery group C1 C2 C3 C4 C5 pro G1 G2 
22 RAMU 35 m discectomy P 13 15.2 19.1 12 0.8 13.4 91 134 
23 HAFEEZAR 54 m # humerus orif P 18 27.3 26.8 34 1.8 14.1 95 172 
24 VINOTH 18 m septorhinoplasty P 17 6.5 6.2 18 15.2 15.1 111 102 
25 JAYASRI 18 F lap appendicectomy P 14 5.8 20 26 13.6 71.5 31 131 
26 amudha 34 F r mastoidectomy P 15 8.01 12.3 19 12.7 110 106 156 
27 sangeetha 21 F lap cholecystectomy P 19 12.42 16.5 32 18.4 54.2 88 92.3 
28 rajendran 50 M r acromioclavicular joint # orif P 16 11.9 13.3 13 11.2 45 72 132 
29 sumathy 39 F sternoclavicular swelling debridement P 9.9 10.8 19.3 19 10.4 95.5 102 111 
30 mala 30 F lap appendicectomy P 36 15.3 25.8 43 29.2 197 90 77 
31 anitha 20 F adenotonsilllectomy P 21 11.8 28 28 18.6 24.6 85 152 
32 renuka 18 F hemithyroidectomy P 12 34.8 15.7 20 10.8 92.9 96 125 
33 kavitha 25 F septorhinoplasty P 13 6.6 10.5 88 10.8 35.9 75 134 
34 iyyappan 28 M lap cholecystectomy P 8.9 8.2 11.2 42 9.1 60.2 113 92 
35 ramu 19 M # clavicle orif P 13 5.7 13.9 28 11.3 35.2 98 174 
36 babu 21 M #nasal bone  P 14 6.3 16.8 32 12.7 56.8 77 129 
37 meenakshi 30 F lap cholecystectomy P 27 19 17.7 44 25.8 25.9 71 143 
38 thalapathy 24 M r mastoidectomy P 8.2 10 11.6 22 9.3 14.9 106 107 
39 NARAYANAN 24 M # nasal bone P 10 11 15.7 16 8..6 45.1 115 119 
40 PAPPA 52 F r mastoidectomy P 5.2 6.4 9 32 6.8 23 76 136 
41 YUVARAJ 23 M lap appendicectomy P 17 16.8 6.7 17 15.6 14.9 82 100 
42 GOPAL 54 M laminectomy P 12 14.5 15.9 7.7 8.3 14.1 85 138 
43 THIRUMURUGAN 36 M # r humerus orif P 9.5 10.8 11.6 14 9.02 45.1 84 101 
 
  
s.n
o 
HR
1 
HR
2 
HR
3 
HR
4 
HR
5 
bp1
sy 
bp1
di 
bp2s
ys 
b2d
ia 
bp3s
ys 
bp3di
as 
bp4s
ys 
bp4diast
ole 
bp5s
ys 
bp5di
as 
DURATI
ON 
SED 
SCORE 
PAIN 
SCORE 
PREO
P C 
INTRAO
P C 
posto
p c 
post extu 
anal 
22 75 71 75 82 
11
0 127 68 126 82 126 84 132 78 130 86 2.2 3 5 0 2 0 1 
23 82 80 68 90 89 120 80 130 70 130 92 120 60 130 70 3 2 4 0 0 0 2 
24 86 81 76 88 79 130 83 105 68 105 78 142 78 150 112 1.4 3 1 2 0 0 2 
25 78 76 72 88 92 126 72 130 30 130 82 142 78 150 112 1.2 2 2 0 0 0 3 
26 93 94 90 89 95 120 56 105 68 112 76 110 80 126 88 3 2 2 0 0 3 3 
27 88 80 78 76 79 130 82 121 74 130 80 120 70 122 80 3 2 3 0 0 0 2 
28 76 75 79 88 80 142 80 130 82 126 90 117 80 120 92 2.3 2 2 0 0 0 2 
29 
10
3 88 85 90 94 126 90 120 80 132 76 126 71 117 80 1.5 2 2 0 0 0 2 
30 93 81 
10
6 96 
10
6 100 92 110 68 116 76 106 84 120 96 2.4 2 4 2 2 3 2 
31 86 80 
11
7 
10
7 98 131 70 120 71 122 73 121 70 140 108 1.1 2 4 0 0 0 2 
32 82 76 79 75 72 117 73 106 80 112 72 128 82 128 78 2.3 2 3 0 0 0 2 
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34 76 72 95 92 83 126 68 124 62 150 92 120 78 112 80 3 2 2 0 1 0 3 
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38 74 80 84 76 72 115 71 106 80 136 92 120 80 126 92 2.5 2 4 0 1 0 2 
39 68 72 83 80 81 106 62 123 84 140 84 120 76 140 88 2.5 3 3 0 1 0 2 
40 63 64 66 64 86 100 58 101 60 150 112 150 106 156 112 3 3 6 0 3 1 1 
41 71 70 83 80 92 126 82 104 78 108 60 112 70 142 78 2 3 2 0 0 0 2 
42 73 68 70 62 88 113 70 106 80 112 70 120 84 130 90 2.2 3 2 0 0 0 2 
43 82 71 68 66 94 104 68 105 70 120 80 123 89 140 110 2.3 3 2 0 0 0 2 
  
 
s.no NAME age sex type of surgery group C1 C2 C3 C4 C5 pro G1 G2 
44 KAUSALYA 28 F lap cholecystectomy P 8.6 9 5.8 32 7.4 106 88 80 
45 SHANTHI 50 F septorhinoplasty P 13 14.5 10.9 24 11.1 82.2 90 90 
46 VENNILA 19 F clavicle# orif P 20 21.3 20.3 44 15.2 84.7 102 122 
47 EZHUMALAI 52 M lap cholecystectomy P 20 22 18.6 38 18.3 78.1 98 107 
48 SURESH 26 M gynaecomasia repair P 32 30.9 22.3 49 20.1 57.2 91 141 
49 ARUL 43 m fess M 5.6 3.1 2.6 9.2 6.8 122 98 200 
50 VEERAPPAN 35 m lap cholecystectomy M 16 11.2 11.6 27 14.6 23.4 93 110 
51 REVATHY 18 f microlaryngeal surgery M 16 10.9 9.2 21 13.1 375 76 103 
52 SURESH 26 m r mastoidectomy M 13 18.1 22.6 30 13 121 72 110 
53 VANITHA 38 f r fibroadenoma excision M 9.4 3.49 3.91 18 11 273 84 76 
54 PRAMILA 27 f hemithyroidectomy M 15 6.3 5 18 12.6 171 92 96 
55 SHANTHI 45 f r mastoidectomy M 10 15.8 20.4 28 11 54.5 87 142 
56 SARAVANAN 28 m lap appendicectomy M 16 18.4 17.3 31 12.3 46 82 138 
57 PARIVENDAN 40 m r radial head excision M 9.3 11.8 9.5 34 10.1 50.7 112 146 
58 SAMIDURAI 36   lipoma chest excision M 8.7 12.1 14.8 11 9.5 24.2 104 91 
59 LOGANATHAN 46 m lap cholecystectomy M 15 19.9 28.4 51 12.9 37.3 89 175 
60 SRINIVASAN 42 m r clavicle# orif M 15 5.6 15.2 18 12.1 28.8 76 133 
61 PARVATHY 20 f lap cholecystectomy M 20 26.1 21.3 31 5.6 93 64 82 
62 SURESH 33 m laminectomy M 22 15.6 24.2 21 12.3 98 82 98 
63 NANDHINI 25 f r vocalcyst excision M 5.4 3.7 3.1 22 6.2 39.6 78 92 
64 RAKESH 19 m l mastoidectomy M 15 6.9 6.4 19 13.6 112 82 81 
65 PUNITHA 28 f nasal bone plasty M 17 7.3 6.9 5.1 14 155 110 110 
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50 71 66 75 82 93 130 84 136 86 140 70 152 122 138 100 3 4 1 0 0 0 2 
51 80 72 91 82 114 122 88 132 74 152 102 132 88 138 84 1 4 5 1 0 3 1 
52 62 68 71 68 61 111 63 110 70 106 68 112 82 107 68 3 4 1 2 0 0 2 
53 84 86 110 102 94 115 78 118 74 138 98 152 80 140 70 1.1 4 6 2 1 2 1 
54 73 83 95 100 97 152 105 138 84 122 92 132 80 150 110 2 4 5 2 0 1 1 
55 91 84 90 73 95 100 70 112 62 138 74 143 76 150 92 2 4 4 2 3 0 1 
56 92 72 91 82 114 96 68 120 88 146 82 121 66 132 77 2.5 4 5 2 2 0 1 
57 80 70 76 67 85 127 69 114 68 134 81 123 72 130 61 2 4 1 2 0 0 2 
58 60 67 91 84 82 122 68 139 76 140 96 142 92 140 78 1.2 4 4 2 0 0 1 
59 63 70 82 75 78 112 72 117 82 132 88 117 78 102 68 3 4 4 2 0 2 1 
60 77 75 79 84 85 122 73 112 64 110 62 134 90 131 72 2.5 4 4 2 0 0 1 
61 74 68 70 73 79 98 72 100 62 112 76 132 76 148 100 2.3 5 6 2 3 0 1 
62 75 77 96 87 119 118 83 128 69 117 85 134 90 142 98 3 5 5 2 0 0 1 
63 85 64 68 71 74 107 68 100 62 127 80 120 76 123 85 1 5 1 1 0 2 2 
64 66 64 71 72 76 110 70 96 72 126 84 124 80 124 78 3 5 2 2 0 0 2 
65 72 70 71 68 74 100 53 120 65 123 70 130 70 140 90 2 5 3 2 0 3 2 
  
 
s.no NAME age sex type of surgery group C1 C2 C3 C4 C5 pro G1 G2 
66 NBANUCHANDER 19 m nasalsinus excision M 14 4 8.7 9.5 12.8 41.1 104 78 
67 MARTIN 45 m lap cholecystectomy M 22 7.3 19.7 37 20.5 108 92 231 
68 SITRARASAN 51 m lumbar mass excision M 15 17.5 16.4 30 13.4 99.4 76 126 
69 VITTABAI 58 f lap cholecystectomy M 23 16.5 25.1 22 13.8 140 80 130 
70 KANAGARAJ 53 m laminectomy M 11 4.6 4.01 20 9.8 103 68 120 
71 ARUNKUMAR 18 m nasal bone #  reduction M 9.8 13.2 15.9 12 12.9 114 78 118 
72 HELENMARY 23 F r mastoidectomy M 21 27 22.3 22 13.2 72.1 80 122 
73 SURYAPRAKASH 18 M fess M 17 12.3 12.7 28 20.6 52.8 70 136 
74 SHANTHI 45 F thyroidectomy M 16 9.8 10.7 22 15.2 48.2 72 141 
75 MURUGAN 27 M # r humerus orif M 15 17.4 16.3 30 11.3 50.3 88 152 
76 MURUGALAKSHMI 50 F r breast mass excision M 12 13.8 11.6 55 10.2 48.6 92 177 
77 GANESAN 28 M r mastoidectomy M 18 7.8 17.4 20 16.8 78.1 96 108 
78 MURUGAN 33 M laminectomy M 17 8.8 8.4 26 16 62.5 101 126 
79 SHANTHI 55 F lipoma axilla r excision M 16 6 10.7 12 13 60.9 102 134 
80 MANI 37 F r gynaecomastectomy M 18 13.3 13.7 29 10.2 56.1 110 123 
81 SEETHA 22 F septorhinoplasty M 12 15.1 17.8 14 10.8 55.3 94 141 
82 SATHYA 18 F r fibroadenoma excision M 9.4 7.9 7.4 26 8.8 48.1 81 139 
83 KALPANA 20 F l fibroadenoma excision M 19 8.1 16.7 27 15.1 64.3 79 92 
84 AMUDHA 36 F laminectomy M 19 14.5 14.8 21 14.3 28.1 83 96 
85 JANAKI 33 F lap cholecystectomy M 15 6.6 7.6 16 10.3 109 92 140 
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72 70 73 81 76 85 100 64 112 80 132 70 126 58 136 90 1.2 5 4 0 0 0 1 
73 75 71 88 81 81 98 70 122 40 140 80 136 76 140 88 1 4 6 2 0 0 1 
74 62 68 76 70 76 120 85 120 70 119 87 130 70 136 80 1.4 4 4 0 0 3 1 
75 65 67 78 72 89 110 71 101 75 130 83 123 79 126 97 1.5 5 4 2 1 0 1 
76 79 84 92 86 97 117 77 121 87 138 90 140 76 146 93 1.1 4 5 2 0 0 1 
77 76 80 97 85 83 105 77 105 68 117 79 130 88 120 76 2 5 4 2 2 2 1 
78 77 83 98 81 72 112 76 98 72 120 80 120 64 118 72 2.4 4 4 2 0 3 1 
79 87 88 
11
2 90 74 120 90 114 68 118 75 121 70 130 68 2.1 5 6 2 0 0 1 
80 68 72 84 92 98 104 58 120 68 130 70 126 86 138 86 3 4 4 2 2 2 1 
81 73 76 93 88 92 120 70 110 70 126 73 130 86 140 90 2.3 4 4 2 0 0 1 
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85 73 66 90 83 81 106 70 112 80 130 100 128 94 130 79 2.3 1 6 0 0 2 1 
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benefits to which you are otherwise entitled. 
 
The results of the special study may be intimated to you at the end of the study 
period or during the study if anything is found abnormal which may aid in the 
management or treatment. 
 
 
 
 
Date: 
 
 
Signature of investigator                                                           Signature of participant 
 
 
 
 
 
  
PROFORMA 
                                                                                                                                                                                                      
Name of the patient:    Age:  Sex:  Wt: 
Insurance No:     OT:      Duration Of Procedure: 
Diagnosis:     Procedure: 
Surgeon:     Anaesthetist: 
                                                                 PREOPERATIVE DETAILS 
ASA Grade     Remarks: 
   
INVESTI
GATIONS 
 
 
VITALS                                                  
 
                                                               
                                                                 INTRAOPERATIVE DETAILS 
I.V Access:      
I.V.Premedication: 
Induction: 
Intubation: 
Position:       
Maintenance: 
N2O O2 Volatile Relaxant 
    
 
 
Time Drugcode 
  
BP Pulse rate Resp. rate SpO2 Temp 
     
Hb RBS RFT Electrolytes ECG X-RAY Others 
       
  
 Intraoperative events if 
any : 
 
 
 
 
 
 
Reversal and extubation: 
 
Recovery  & postoperative period:    
 alert/ drowsy          comfortable/uncomfortable             ponv- yes/no      pain- yes/no 
                                                            
                                                    STUDY  PARAMETERS 
                                                                                                     
 
 
 
 
 
 
 
 
 
 
Time & 
Parameter 
O MIN 3O MIN 60 MIN 120 
MIN 
180 
MIN 
RR      
Temp      
ECG      
Etco2      
U/O  
IVF  
Time 
[min] 
 0 15 30 45 60 75 90 105 120 135 150 165 180 
HR/min              
BP 
mmHg 
             
  
 Lab values Baseline 
Postpremedication 
Post 
intubation 
Postextubation Post 
operative 
Serum 
cortisol[µg/dl] 
 
 
   
Plasma 
glucose 
 
 
   
Serum 
prolactin 
 
 
   
 
